9814:HK:HK-Samsung NYSE FANG+ ETF (USD)

ETF | Others |

Last Closing

USD 4.542

Change

+0.01 (+0.26)%

Market Cap

N/A

Volume

0.10M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.03 (-0.15%)

USD 146.84B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.04 (+0.06%)

USD 24.81B
2823:HK iShares FTSE A50 China

+0.14 (+0.99%)

USD 21.23B
2801:HK iShares Core MSCI China ETF

-0.30 (-1.42%)

USD 20.56B
83188:HK ChinaAMC CSI 300 Index ETF

+0.38 (+0.92%)

USD 13.48B
82822:HK CSOP FTSE China A50

+0.12 (+0.97%)

USD 9.69B
9067:HK iShares Hang Seng TECH ETF

N/A

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.02 (+0.16%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

-0.26 (-3.59%)

USD 3.03B

ETFs Containing 9814:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.41% 88% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.41% 88% B+ 83% B
Trailing 12 Months  
Capital Gain 49.41% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.41% 88% B+ 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.80% 81% B- 69% C-
Dividend Return 6.80% 80% B- 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.55% 54% F 79% B-
Risk Adjusted Return 38.75% 81% B- 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike